Superannuation fund trustees will have to ensure members meet new stringent requirements if they are to receive benefits from SIS-related lump sum and disability income products, DEXX&R reports.
In the latest DEXX&R Digest, the research company revealed that a number of changes to SIS-related products had been made to most individual total permanent disability (TPD) and disability income products, and group based TPD, salary continuance benefits in personal and employer super products.
DEXX&R reported that lump sum SIS changes made to inside super products varied from product to product, however, all now include wording that benefits would only be paid to the trustee if they met the SIS definition of temporary or permanent incapacity.
“For death products terminal illness benefits inside super now need to be certified by two doctors, [however] outside super this remains one doctor for most products,” DEXX&R said.
“For TPD products the 'own occupation’ definition has been removed although Own Occupation continues to be available in Australian Super for low risk professionals and managers.
“In addition the unable to earn 25 per cent of income tier of the Education Training or Experience (ETE) definition has been removed from ETE definitions inside super.”
DEXX&R said there had been a number of major SIS changes to disability income products inside super including the removal of agreed value monthly benefits from some products, and the inclusion of an explicit statement that the insured must cease gainful employment for at least one day in some products that only require total or partial disablement during the waiting period.
Other disability income SIS changes included:
The lower outlook for inflation has set the stage for another two rate cuts over the first half of 2026, according to Westpac.
With private asset valuations emerging as a key concern for both regulators and the broader market, Apollo Global Management has called on the corporate regulator to issue clear principles on valuation practices, including guidance on the disclosures it expects from market participants.
Institutional asset owners are largely rethinking their exposure to the US, with private markets increasingly being viewed as a strategic investment allocation, new research has shown.
Australia’s corporate regulator has been told it must quickly modernise its oversight of private markets, after being caught off guard by the complexity, size, and opacity of the asset class now dominating institutional portfolios.